WuXi Biologics (2269)

70.85
-1.10(-1.53%)
  • Volume:
    11,791,463
  • Bid/Ask:
    70.85/70.90
  • Day's Range:
    69.90 - 72.25

2269 Overview

Prev. Close
71.95
Day's Range
69.9-72.25
Revenue
11.96B
Open
72
52 wk Range
38.2-127.5
EPS
0.812
Volume
11,791,463
Market Cap
302.13B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
22,564,962
P/E Ratio
84.96
Beta
0.908
1-Year Change
-42.12%
Shares Outstanding
4,264,431,011
Next Earnings Date
-
What is your sentiment on WuXi Biologics?
or
Market is currently closed. Voting is open during market hours.

WuXi Biologics Analysis

WuXi Biologics Company Profile

WuXi Biologics Company Profile

Employees
9864
Market
Hong Kong

WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People’s Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuySellStrong SellSell
Technical IndicatorsStrong BuyStrong BuyBuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyNeutralStrong SellStrong Sell